Association of intratumoral pharmacokinetics of fluorouracil with clinical response.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  The Lancet

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 7909867
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A mathematical model of the kinetics of 5-fluorouracil and its metabolites in cancer patients

  2004cited by this paper
• Effect of pH on tumor cell uptake of radiogallium in vitro and in vivo

  2004cited by this paper
• The non-invasive monitoring of low dose, infusional 5-fluorouracil and its modulation by interferon-alpha using in vivo 19F magnetic resonance spectroscopy in patients with colorectal cancer: a pilot study.

  1993cited by this paper
• In vivo measurements of intratumoral metabolism, modulation, and pharmacokinetics of 5-fluorouracil, using 19F nuclear magnetic resonance spectroscopy.

  1991cited by this paper
• pH dependence of 5-fluorouracil uptake observed by in vivo 31P and 19F nuclear magnetic resonance spectroscopy.

  1991cited by this paper
• Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits.

  1990cited by this paper
• Human tumor fluorouracil trapping: clinical correlations of in vivo 19F nuclear magnetic resonance spectroscopy pharmacokinetics.

  1990cited by this paper
• Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivo.

  1989cited by this paper
• Fluorine-19 NMR spectroscopic studies of the metabolism of 5-fluorouracil in the liver of patients undergoing chemotherapy.

  1987cited by this paper
• Toxicity and response criteria of the Eastern Cooperative Oncology Group

  1982cited by this paper
• Facilitated transport of uracil and 5‐fluorouracil, and permeation of orotic acid into cultured mammalian cells

  1980cited by this paper
• Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893).

  1974cited by this paper

• Mechanistic Modelling of Transdermal Delivery Dependence on Drug Properties.

  2026cites this paper
• Development of a 3D Human Colon Model Along with Bioelectronics for the Induction and Monitoring of Diseases

  2025cites this paper
• Image-based multiphysics modelling of thermosensitive liposome-mediated drug delivery to liver tumour under high-intensity focused ultrasound heating

  2025cites this paper
• An RF coil design to enable quintuple nuclear whole‐brain MRI

  2023cites this paper
• The evaluation of anticancer activity by synthesizing 5FU loaded albumin nanoparticles by exposure to UV light.

  2022cites this paper
• Seed- and Soil-Dependent Differences in Murine Breast Tumor Microenvironments Dictate Anti-PD-L1 IgG Delivery and Therapeutic Efficacy

  2021cites this paper
• The Unique Pharmacometrics of Small Molecule Therapeutic Drug Tracer Imaging for Clinical Oncology

  2020cites this paper
• Dose Issues in Cancer Chemotherapy

  2020cites this paper
• Tumor Site-Dependent Transport Properties Determine Nanotherapeutics Delivery and Its Efficacy

  2019cites this paper
• In-Vivo Retention of 5-Fluorouracil Using 19F Magnetic Resonance Chemical Shift Imaging in Colorectal Cancer in a Murine Model

  2019cites this paper
• Methods and Study Designs for Characterizing the Pharmacokinetics and Pharmacodynamics of Carrier-Mediated Agents.

  2018cites this paper
• Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis?

  2018cites this paper
• Drug transport-based therapeutic resistance in breast cancer liver metastases.

  2018cites this paper
• Synthesis of 99mTc-Radiolabeled Uridine as a Potential Tumor Imaging Agent

  2018cites this paper
• Insights on animal models to investigate inhalation therapy: Relevance for biotherapeutics.

  2018cites this paper
• Preclinical pharmacokinetic profiling of IQG‐607, a potential oral metallodrug to treat tuberculosis

  2018cites this paper
• Multiscale models for transport and biodistribution of therapeutics in cancer

  2018cites this paper
• Progression‐dependent transport heterogeneity of breast cancer liver metastases as a factor in therapeutic resistance

  2018cites this paper
• IMB-SD62, a triazolothiadiazoles derivative with promising action against tuberculosis.

  2018cites this paper
• Tumor progression effects on drug vector access to tumor‐associated capillary bed

  2017cites this paper
• 2, 4-Ditellurouracil and its 5-fluoro derivative: Theoretical investigations of structural, energetics and ADME parameters

  2017cites this paper
• Insights on animal models to investigate inhalation therapy: relevance for biotherapeutics

  2017cites this paper
• A DFT analysis of the molecular structure, vibrational spectra and other molecular properties of 5-nitrouracil and comparison with uracil

  2016cites this paper
• Microdialysis-directed Intra-tumor Pharmacokinetic Modeling of Methotrexate in Mice and Humans.

  2016cites this paper
• Computational analysis of drug transport in tumor microenvironment as a critical compartment for nanotherapeutic pharmacokinetics

  2016cites this paper
• 6-Aminouracil: Geometries and spectra in the isolated state and in the solid state simulation. A comparison with 5-aminouracil

  2016cites this paper
• Image-driven pharmacokinetics: nanomedicine concentration across space and time.

  2015cites this paper
• Capillary collagen as the physical transport barrier in drug delivery to tumor microenvironment

  2015cites this paper
• 19 F MRSI of capecitabine in the liver at 7 T using broadband transmit–receive antennas and dual‐band RF pulses

  2015cites this paper
• A Hypothesis Concerning the Effect of Schedule on the Pattern of 5-Fluorouracil Toxicity

  2015cites this paper
• Liposomal doxorubicin extravasation controlled by phenotype-specific transport properties of tumor microenvironment and vascular barrier.

  2015cites this paper
• Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline

  2014cites this paper
• Microdialysis: A Real-Time Sampling Technique for More Effective Pharmacokinetic- Pharmacodynamic Studies in Drug Research and

  2014cites this paper
• Positron Emission Tomography/Magnetic Resonance Imaging Evaluation of Lung Cancer: Current Status and Future Prospects

  2014cites this paper
• Magnetic Resonance Spectroscopy of Cancer Metabolism and Response to Therapy

  2012cites this paper
• Analysis of anti-cancer drug penetration through multicell layers in vitro : the development and evaluation of an in vitro model for assessing the impact of convective fluid flow on drug penetration through avascular cancer tissues

  2012cites this paper
• One Step Closer to the Target: Intracellular Pharmacokinetics of Gemcitabine

  2012cites this paper
• Diffusion and binding of 5-fluorouracil in non-ionic hydrogels with interpolymer complexation.

  2012cites this paper
• The challenges of integrating molecular imaging into the optimization of cancer therapy.

  2011cites this paper
• The Unique Potential for Noninvasive Imaging in Modernizing Drug Development and in Transforming Therapeutics: PET/MRI/MRS

  2011cites this paper
• Fluorine (19F) MRS and MRI in biomedicine

  2011cites this paper
• Noninvasive detection of carboxypeptidase G2 activity in vivo

  2011cites this paper
• Correlating magnetic resonance findings with neuropathology and clinical signs in dogs and cats.

  2011cites this paper
• Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study

  2010cites this paper
• The effects of drug transporter inhibitors on the pharmacokinetics and tissue distribution of methotrexate in normal and tumor-bearing mice: a microdialysis study

  2010cites this paper
• Can localised 19F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response?

  2010influential citation
• Microdialysis for assessing intratumoral drug disposition in brain cancers: a tool for rational drug development

  2010cites this paper
• Relationships observed in the structure and spectra of uracil and its 5-substituted derivatives.

  2010cites this paper
• FT-IR and FT-Raman spectra, ab initio and density functional computations of the vibrational spectra, molecular geometry, atomic charges and some molecular properties of the biomolecule 5-iodouracil

  2010cites this paper
• Simulation of a tetramer form of 5-iodouracil: The vibrational spectra and molecular structure in the isolated and in the solid state by using DFT calculations

  2010cites this paper
• A novel technique to monitor carboxypeptidase G2 expression in suicide gene therapy using 19F magnetic resonance spectroscopy

  2009cites this paper
• Magnetic resonance imaging and spectroscopy.

  2008cites this paper
• Preparation and pharmacological evaluation of a new radiopharmaceutical, technetium-99m-5-fluorouracil, for tumor scintigraphy.

  2008cites this paper
• Polyethylene glycol (PEG) as a key component of long-circulating delivery systems for therapy and imaging

  2008cites this paper
• Fluorine-18-labeled 5-fluorouracil is a useful radiotracer for differentiation of malignant tumors from inflammatory lesions

  2008cites this paper
• Drug‐binding Cavities in Long‐Lived Biologics: Cause for Concern but Also Potential Benefit

  2008cites this paper
• A well-tolerated 5-FU-based treatment subsequent to severe capecitabine-induced toxicity in a DPD-deficient patient.

  2008cites this paper
• Modified vaccinia virus Ankara as a vector for suicide gene therapy

  2008cites this paper
• Clinical Microdialysis in Skin and Soft Tissues: An Update

  2008cites this paper
• Non‐Invasive Physiology and Pharmacology Using 19F Magnetic Resonance

  2008cites this paper
• Quantitative 19F MR spectroscopy at 3 T to detect heterogeneous capecitabine metabolism in human liver

  2007cites this paper
• Chemotherapy dosing part I: scientific basis for current practice and use of body surface area.

  2007cites this paper
• Plasma and Tissue Pharmacokinetics of Epirubicin and Paclitaxel in Patients Receiving Neoadjuvant Chemotherapy for Locally Advanced Primary Breast Cancer

  2007cites this paper
• Positron Emission Tomography Measurement of Drug Kinetics

  2007cites this paper
• Applications of 19F‐NMR to Oncology

  2007cites this paper
• VatuximabTM: Optimizing Therapeutic Strategies for Prostate Cancer Based on Dynamic MR Tumor Oximetry

  2007cites this paper
• 21 – Carrier-mediated and artificial-cell targeted cancer drug delivery

  2007cites this paper
• Assessment of induced rat mammary tumour response to chemotherapy using the apparent diffusion coefficient of tissue water as determined by diffusion-weighted1H-NMR spectroscopy in vivo

  2007cites this paper
• Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy

  2007cites this paper
• Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium‐DTPA‐enhanced MRI and localized 19F MRS pharmacokinetic studies of 5‐fluorouracil

  2007influential citation
• des quantitativen immunhistochemischen Nachweises von Protein S100A6 beim Mammakarzinom

  2006cites this paper
• Recent developments in the clinical pharmacology of classical cytotoxic chemotherapy.

  2006cites this paper
• Die Bedeutung des quantitativen immunhistochemischen Nachweises von Protein S100A6 beim Mammakarzinom

  2006cites this paper
• Advances in Brief Intratumoral Conversion of 5-Fluorocytosine to 5-Fluorouracil by Monoclonal Antibody-Cytosine Deaminase Conjugates : Noninvasive Detection of Prodrug Activation by Magnetic Resonance Spectroscopy and Spectroscopic Imaging 1

  2006cites this paper
• MR for Clinical Pharmacological Studies in Cancer

  2006cites this paper
• Application of microdialysis in clinical pharmacology.

  2006cites this paper
• Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution

  2006cites this paper
• Reducing Whole Body Physiologically Based Pharmacokinetic Models Using Global Sensitivity Analysis: Diazepam Case Study

  2006cites this paper
• The relevance of microdialysis for clinical on:cology.

  2006cites this paper
• Microdialysis

  2005cites this paper
• Pharmacodynamics and pharmacokinetics of SQ109, a new diamine‐based antitubercular drug

  2005cites this paper
• Quantitative assessment of the hepatic pharmacokinetics of the antimicrobial sitafloxacin in humans using in vivoF magnetic resonance spectroscopy.

  2005cites this paper
• An 19F Magnetic Resonance–Based In Vivo Assay of Solid Tumor Methotrexate Resistance: Proof of Principle

  2005cites this paper
• Monitoring fluoropyrimidine metabolism in solid tumors with in vivo (19)F magnetic resonance spectroscopy.

  2005cites this paper
• 19F: a versatile reporter for non-invasive physiology and pharmacology using magnetic resonance.

  2005cites this paper
• Tissue penetration of cefpodoxime into the skeletal muscle and lung in rats.

  2005cites this paper
• Microdialysis for in vivo pharmacokinetic/pharmacodynamic characterization of anti-infective drugs.

  2005cites this paper
• Proceedings of the Engineering and Physical Sciences Research Council Workshop—the development of functional imaging in the diagnosis, management and understanding of childhood brain tumours

  2005cites this paper
• Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumours

  2005cites this paper
• Methods to assess tissue-specific distribution and metabolism of drugs.

  2004cites this paper
• Established and emerging roles of liposomal anthracyclines in oncology. Introduction.

  2004cites this paper
• Novel fluoropyrimidines: improving the efficacy and tolerability of cytotoxic therapy.

  2004cites this paper
• Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high‐field 19F‐NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols

  2004cites this paper
• Reply

  2004cites this paper
• Use of Microdialysis in Preclinical and Clinical Development of Anticancer Agents

  2004cites this paper
• Tumor‐based pharmacokinetics has greater significance for anticancer drugs than does blood‐based pharmacokinetics

  2004cites this paper
• Microdialysis

  2004cites this paper
• Microdialysis in drug discovery.

  2004cites this paper
• Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Distribution in Tissue

  2004influential citation
• Molecular imaging in oncology

  2004cites this paper